These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 71400)

  • 21. Assay of debrisoquine and 4-hydroxydebrisoquine in urine by reversed-phase high-performance liquid chromatography using on-line sample clean-up on a standard isocratic chromatograph.
    Moncrieff J
    J Chromatogr; 1988 Jun; 428(1):178-82. PubMed ID: 3170673
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection.
    Lennard MS; Silas JH; Smith AJ; Tucker GT
    J Chromatogr; 1977 Mar; 133(1):161-6. PubMed ID: 838796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct determination of debrisoquine and 4-hydroxydebrisoquine using a high-performance liquid chromatographic switching technique.
    Decolin D; Nicolas A; Motassim N; Siest G
    J Chromatogr; 1987 Aug; 419():469-74. PubMed ID: 3667807
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for the polymorphic oxidation of debrisoquine in the Thai population.
    Wanwimolruk S; Patamasucon P; Lee EJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):244-7. PubMed ID: 2306417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically determined oxidation capacity and the disposition of debrisoquine.
    Sloan TP; Lancaster R; Shah RR; Idle JR; Smith RL
    Br J Clin Pharmacol; 1983 Apr; 15(4):443-50. PubMed ID: 6849780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Debrisoquine hydroxylation polymorphism in diabetic patients.
    Kallio J; Huupponen R; Viikari J
    Diabetes Res; 1990 Nov; 15(3):125-9. PubMed ID: 2132205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
    Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Dixon ST; McLean AJ
    J Chromatogr; 1986 Jan; 374(1):204-8. PubMed ID: 3949931
    [No Abstract]   [Full Text] [Related]  

  • 29. Liquid chromatographic method for the determination of debrisoquine and its 4-hydroxy metabolite in human urine.
    Róna K; Vereczkey L; Gachályi B
    J Chromatogr; 1986 Jun; 378(2):509-13. PubMed ID: 3734009
    [No Abstract]   [Full Text] [Related]  

  • 30. Diazepam treatment does not influence the debrisoquine or mephenytoin hydroxylation phenotyping tests.
    Spina E; Buemi AL; Sanz E; Bertilsson L
    Ther Drug Monit; 1989 Nov; 11(6):721-3. PubMed ID: 2595755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.
    Xu XM; Jiang WD
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):385-8. PubMed ID: 2130590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers.
    Cerqueira PM; Mateus FH; Cesarino EJ; Bonato PS; Lanchote VL
    J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):153-61. PubMed ID: 11145052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.
    Steiner E; Iselius L; Alván G; Lindsten J; Sjöqvist F
    Clin Pharmacol Ther; 1985 Oct; 38(4):394-401. PubMed ID: 4042522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine.
    Johnson KA; Kolatkar V; Straka RJ
    Ther Drug Monit; 1990 Sep; 12(5):478-80. PubMed ID: 2293411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results.
    Vincent-Viry M; Deshayes S; Mothe O; Siest G; Galteau MM
    J Pharm Pharmacol; 1988 Oct; 40(10):695-700. PubMed ID: 2907535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.
    Yue QY; Svensson JO; Alm C; Sjöqvist F; Säwe J
    Br J Clin Pharmacol; 1989 Dec; 28(6):639-45. PubMed ID: 2611086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A micromethod for quantitation of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography.
    Pereira VA; Auler JO; Carmona MJ; Mateus FH; Lanchote VL; Breimer DD; Santos SR
    Braz J Med Biol Res; 2000 May; 33(5):509-14. PubMed ID: 10775881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the frequency distribution of debrisoquine hydroxylation deficiency in Chinese healthy Zang and Wei volunteers].
    Kuang TY; Liao XM; Wang KY; Zhang Y; Lou YQ
    Yao Xue Xue Bao; 1991; 26(4):250-4. PubMed ID: 1957669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphic hydroxylation of debrisoquine.
    Tucker GT; Silas JH; Iyun AO; Lennard MS; Smith AJ
    Lancet; 1977 Oct; 2(8040):718. PubMed ID: 71525
    [No Abstract]   [Full Text] [Related]  

  • 40. Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine.
    Eichelbaum M; Bertilsson L; Küpfer A; Steiner E; Meese CO
    Br J Clin Pharmacol; 1988 Apr; 25(4):505-8. PubMed ID: 3382592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.